Pulikkotil SJ, Nagendrababu V, Veettil SK, Jinatongthai P, Setzer FC. Effect of oral premedication on the anaesthetic efficacy of inferior alveolar nerve block in patients with irreversible pulpitis -A systematic review and network meta-analysis of randomized controlled trials. Journal, 51, 989-1004Journal, 51, 989- , 2018 This systematic review (SR; PROSPERO database: CRD42017075160) and network meta-analysis (NMA) identified the most effective oral premedication for anaesthetic success of inferior alveolar nerve blocks (IANB) in cases of irreversible pulpitis. Medline and Ebscohost databases were searched up until 10/2017. Randomized controlled trials (RCT) studying the effect of oral premedication, alone or in combination, on the success of IANB for cases of irreversible pulpitis, compared to placebo or other oral premedications, were included. Quality of the included studies was appraised by the revised Cochrane risk of bias tool for randomized trials. Pairwise analysis, NMA and quality of evidence assessment using GRADE criteria were performed. Nineteen studies (n = 1654 participants) were included. NMA demonstrated that compared to placebo, dexamethasone was most effective in increasing . Sensitivity analyses proved the superiority of dexamethasone or NSAIDs over any other premedications. Subgroup analyses of specific dosages in comparison with placebo demonstrated that dexamethasone 0.5 mg was most effective, followed by ketorolac 10 mg, piroxicam 20 mg, ibuprofen 400 mg + acetaminophen 500 mg and Tramadol 50 mg. Ibuprofen 400 mg, 600 mg and 800 mg had a significantly improved IANB success, while Ibuprofen 300 mg had no effect. Oral premedication with dexamethasone, NSAIDs or Tramadol significantly increased anaesthetic success. More trials are needed to evaluate the premedication effects of dexamethasone or Tramadol for improved anaesthetic success of IANB when treating irreversible pulpitis.
This systematic review (SR; PROSPERO database: CRD42017075160) and network meta-analysis (NMA) identified the most effective oral premedication for anaesthetic success of inferior alveolar nerve blocks (IANB) in cases of irreversible pulpitis. Medline and Ebscohost databases were searched up until 10/2017. Randomized controlled trials (RCT) studying the effect of oral premedication, alone or in combination, on the success of IANB for cases of irreversible pulpitis, compared to placebo or other oral premedications, were included. Quality of the included studies was appraised by the revised Cochrane risk of bias tool for randomized trials. Pairwise analysis, NMA and quality of evidence assessment using GRADE criteria were performed. Nineteen studies (n = 1654 participants) were included. NMA demonstrated that compared to placebo, dexamethasone was most effective in increasing anaesthetic success (RR, 2.92 [95% CI 1.74, 4 .91]; SUCRA = 0.96), followed by NSAIDs (RR, 1.92 [95% CI 1.63,2.27], SUCRA = 0.738) and Tramadol (RR, 2.03 [95% CI 1.18, 3.49] , SUCRA = 0.737). Premedication with acetaminophen added to NSAIDs demonstrated similar efficacy as NSAIDs alone (RR, 1.06 [95% CI 0.79, 1.43] ). Sensitivity analyses proved the superiority of dexamethasone or NSAIDs over any other premedications. Subgroup analyses of specific dosages in comparison with placebo demonstrated that dexamethasone 0.5 mg was most effective, followed by ketorolac 10 mg, piroxicam 20 mg, ibuprofen 400 mg + acetaminophen 500 mg and Tramadol 50 mg. Ibuprofen 400 mg, 600 mg and 800 mg had a significantly improved IANB success, while Ibuprofen 300 mg had no effect. Oral premedication with dexamethasone, NSAIDs or Tramadol significantly increased anaesthetic success. More trials are needed to evaluate the premedication effects of dexamethasone or Tramadol for improved anaesthetic success of IANB when treating irreversible pulpitis.
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Introduction
The inferior alveolar nerve block (IANB) is used to achieve anaesthesia of mandibular teeth. The failure rate for IANB in patients with irreversible pulpitis has been reported to be between 43% and 83%, which was attributed to inflammatory changes in the pulp (Reisman et al. 1997 , Nusstein et al. 1998 , Lindemann et al. 2008 , Argueta-Figueroa et al. 2012 , Fowler et al. 2016 , Aggarwal et al. 2017 . Minimizing the failure rate of IANB is important for both patients and clinicians (Walton et al. 2008) . Supplemental techniques such as intraosseous anaesthesia , buccal infiltration (Aggarwal et al. 2009 ), periodontal ligament injection (Kim 1986 ) and oral premedication (Lapidus et al. 2016 , Tupyota et al. 2017 have been used to increase the success of anaesthesia for mandibular teeth.
A variety of pharmacological agents such as nonsteroidal anti-inflammatory drugs (NSAIDs) and steroids have been investigated as oral premedication to increase the success of anaesthesia in randomized controlled trials (Prasanna et al. 2011 , Shahi et al. 2013 , Yadav et al. 2015 . Previous meta-analyses have shown that the use of oral premedication with NSAIDs increased the success rate of IANB in patients with irreversible pulpitis (Li et al. 2012 , Lapidus et al. 2016 , Corbella et al. 2017 , Shirvani et al. 2017 , Tupyota et al. 2017 . However, in the absence of comprehensive head-to-head comparisons among different NSAIDs and other oral premedications, their relative efficacy is not known.
Network meta-analysis, in contrast to conventional pairwise meta-analysis, allows for the combination of direct and indirect evidence among interventions (various oral premedications) across a network of randomized controlled trials of all compounds so far tested in the respective field (Tonin et al. 2017) . A network meta-analysis assumes that the studies investigated within the network are conceptually similar with respect to design, participants, interventions and outcome assessment. Hence, a network meta-analysis could improve the precision of an estimate in comparison with the evidence from pairwise meta-analysis and also permit an assessment of the comparative efficacy of two active interventions, even if no studies directly compare them (Kiefer et al. 2015 , Tonin et al. 2017 . The absence of comparative efficacy data for various oral premedications is a serious lack of evidence in the existing literature.
The aim of this study was to perform a network meta-analysis to compare the relative efficacy of competing oral premedications used to increase the success rate of IANB in patients with irreversible pulpitis. GRADE (Grading of Recommendations, Assessment, Development and Evaluation) criteria adapted to network meta-analysis were used to rate the quality of evidence of estimates (Puhan et al. 2014) . The results of this analysis aim to provide dentists with useful information to make evidence-based decisions on the most effective oral premedication that can effectively increase the success of IANB for treatment of patients with irreversible pulpitis. To accomplish the aim, a research questions was framed based on PICOS: Which is the most effective oral premedication in increasing the anaesthetic success of Inferior Alveolar Nerve Block in patients with irreversible pulpitis undergoing root canal treatment in randomized control trials (RCTs)?
Review

Study design
The systematic review protocol was registered in PROSPERO (CRD42017075160) and followed the PRISMA extension statement for reporting systematic reviews incorporating network meta-analyses of healthcare interventions (Hutton et al. 2015) .
Inclusion criteria
Randomized controlled trials evaluating the effects of any oral premedication, alone or in combination, on the success of IANB in adult patients undergoing nonsurgical root canal treatment on teeth with irreversible pulpitis, compared to placebo or other oral premedications, were considered for inclusion in the systematic review. The primary outcome of interest was the success of IANB anaesthesia during access preparation and root canal instrumentation.
Literature search
Two electronic databases (Medline and EbscohostDentistry & Oral Sciences Source) and two trial registries (Cochrane Central Register of Control Trials -CENTRAL, ClinicalTrials.gov.) were searched for relevant studies from inception up to October 2017. The search strategy for Medline and Ebscohost is shown in Table S1 and Table S2 , respectively. No Oral premedication and anaesthetic efficacy Pulikkotil et al.
language restrictions were used for the search. Crossreferencing from the bibliographic lists of identified studies, published reviews and standard textbooks was carried out to discern additional studies for inclusion. Following initial screening through title and abstract review, two independent reviewers evaluated the full text of studies identified for inclusion. Any disagreement towards inclusion was resolved by consensus and by an arbitrator for any unresolved disagreements.
Data extraction
The data extraction form followed the Cochrane Handbook for Systematic Reviews of Interventions guidelines and consisted of: (i) study characteristics: name of the first author, year, intervention arms, number of samples, local anaesthetic agent used, (ii) participant characteristics -age, sex, type of tooth, (iii) types of intervention and comparator(s): time of drug delivery and dosage, (iv) primary outcome measures: success rate of IANB anaesthesia. Two independent, calibrated reviewers extracted the data from the included studies. Any disagreement was resolved by consensus or arbitration by the third reviewer.
Quality assessment
Two independent reviewers evaluated the quality of the included studies to determine risk of bias (ROB) using the using the revised Cochrane risk of bias tool for randomized trials (RoB 2.0) (Higgins et al. 2016) . Randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, selection of the reported result were individually assessed by two reviewers who classified the selected studies as 'low risk of bias', 'some concerns' and 'high risk of bias'. Any disagreement in quality assessment was brought to conclusion by review team discussion or by one of the arbitrators.
Evidence grading
The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) (GRADEpro GDT: GRADEpro Guideline Development Tool [Software], McMaster University, 2015 (developed by Evidence Prime, Inc.)) approach adapted to network meta-analysis was used to objectively rate the quality of evidence of estimates as 'high', 'moderate', 'low' and 'very low' (Puhan et al. 2014) .
Network meta-analysis Statistical analysis
Standard pairwise meta-analysis using a randomeffects model was performed for comparison of direct evidence among studies. Heterogeneity by I2 statistics was determined when two or more studies had data for direct comparison. Substantial heterogeneity among studies was present when I2 was greater than 50%. Risk ratio (RR), of the success rates of intervention to the comparison, was calculated with 95% confidence interval (CI). Stata version 14.1 (StataCorp, College Station, TX, USA) was used to combine the direct and indirect evidence from the selected studies to carry out a random-effects network meta-analysis. As described by Veroniki et al. (2013) , direct and indirect evidence was contrasted using the triangular loop method. Disagreement between the direct and indirect estimates which indicates network inconsistency assumption was studied by a design-by-treatment interaction approach (global inconsistency) (Bucher et al. 1997) . The surface area under the cumulative ranking (SUCRA) curves (Salanti et al. 2011 ) was used to rank the various oral premedications on the success of IANB. Higher SUCRA scores nearing one (range 0 to 1) corresponded to higher ranking for the oral premedication leading to higher success of IANB. The effect of anaesthetic agents (restricted to trials that used lidocaine as anaesthetic solution), variation in volume of the anaesthetic agents (restricted to trials that used 1.8 mL), quality of studies (low risk of bias) and sample size (Dechartres et al. 2014) (excluding trials with small sample size (<25th percentiles)) on the primary outcome were examined by sensitivity analyses. Comparisonadjusted funnel plot was employed to determine publication bias. A subgroup analysis was performed based on the dose of oral premedication as reported in the selected studies.
Results
Study selection
The process of study selection is depicted in the PRISMA flow diagram in Fig. 1 . The initial search led to the identification of 725 studies. Of these, 98 articles were removed as duplicates. A further 607 records were excluded as the title and/or abstract review revealed that the studies were not relevant to this research question. All of the remaining 20 studies were retrieved for full-text review. All studies were published in English. After full-text assessment, one study (Modaresi et al. 2006) was excluded due to absent reporting of anaesthetic evaluation during access preparation. Nineteen studies (Ianiro et al. 2007 , Aggarwal et al. 2010 , Oleson et al. 2010 , Parirokh et al. 2010 , Singh et al. 2010 , Paul et al. 2011 , Prasanna et al. 2011 , Simpson et al. 2011 , Khademi et al. 2012 , Wali et al. 2012 , Jena & Shashirekha 2013 , Madani et al. 2013 , Noguera-Gonzalez et al. 2013 , Shahi et al. 2013 , Fullmer et al. 2014 , Jalil et al. 2014 , Saha et al. 2016 , Mahajan et al. 2017 , Shantiaee et al. 2017 were finally included in the systematic review and the network meta-analysis.
Characteristics of the included studies
Following the selection criteria, studies identified were conceptually similar. Table 1 shows the characteristics of the included studies. The total number of participants was n = 1654 and consisted of both men and women of ages ranging between 17 and 68 years. Only one study used mepivacaine as the anaesthetic agent while lignocaine/lidocaine and Oral premedication and anaesthetic efficacy Pulikkotil et al. Table 1 Characteristic of included studies 
Quality assessment of the trials
The quality of the 20 included studies was assessed using the Cochrane revised risk of bias guidelines as given in Table S3 . Twelve studies (Ianiro et al. 2007 , Aggarwal et al. 2010 , Oleson et al. 2010 , Parirokh et al. 2010 , Prasanna et al. 2011 , Simpson et al. 2011 , Khademi et al. 2012 , Noguera-Gonzalez et al. 2013 , Shahi et al. 2013 , Fullmer et al. 2014 , Saha et al. 2016 , Shantiaee et al. 2017 ) demonstrated low risk of bias, five studies high risk of bias (Singh et al. 2010 , Paul et al. 2011 , Wali et al. 2012 , Jena & Shashirekha 2013 , Jalil et al. 2014 , due to bias in the randomization process and measurement of the outcome. The remaining two studies (Madani et al. 2013 , Mahajan et al. 2017 were found to have some concerns in regard to risk of bias. In all the studies, intervention and outcome assessment was performed in the same visit and as a result, no dropouts were recorded, eliminating this potential for bias.
Pairwise meta-analysis 
Network meta-analysis
The primary network meta-analysis was limited to seven interventions (alprazolam, acetaminophen (ACM), dexamethasone, nonsteroidal antiinflammatory drug (NSAID), Tramadol, combination of NSAID and ACM and combination of ACM and hydrocodone (HC); Fig. 2 ), which were ranked based on their effects on IANB anaesthesia. The results of the network meta-analysis (estimated RR and SUCRA ranks) for interventions on success of IANB anaesthesia from all trials are given in Table S5 . Contribution plots presenting the influence of each direct evidence are presented in Figure S1 . SUCRA curves and predictive interval plot for the efficacy outcome are presented in Figure S2 and Figure S3 , respectively. Network meta-analytic results on success of IANB anaesthesia from all trials were comparable with those from standard pairwise meta-analysis (Fig. 3) plots for the success of IANB anaesthesia for all interventions are provided in Fig. 4 . Assessed for comparative efficacy (Fig. 3) 
Sensitivity analyses
The results from multiple sensitivity analyses are presented based on low risk of bias trials ( Figure S4 ), trials with 1.8 mL volume of anaesthesia ( Figure S5 ), trials using lidocaine as anaesthetic agent ( Figure S6 ) and omission of small size trials ( Figure S7) . Overall, the results were robust to the changes in sensitivity analyses and dexamethasone and NSAIDs remained superior to comparators (Table S6 ).
Subgroup analysis
When individual NSAIDs and other interventions with specific doses were considered (25 interventions including placebo for network comparison; Fig. 5 Outcomes are expressed as risk ratios (95% confidence intervals). For the pairwise meta-analyses, risk ratio more than 1 indicates that the treatment specified in the column is more efficacious. For the network meta-analysis, risk ratio more than 1 indicates that the treatment specified in the row is more efficacious. Green-shaded results indicate statistical significance. Comparison between treatments should be read from column to row (row treatment is reference). ALPRA, alprazolam; ACM, acetaminophen; HC, hydrocodone; DEXA, dexamethasone; NSAID, nonsteroidal anti-inflammatory drug; TRAMA, Tramadol. Figure 4 Ranking plots for the efficacy outcome: primary network meta-analysis for oral premedications on the anaesthetic efficacy of Inferior Alveolar Nerve Block. Higher SUCRA scores (ranging from 0 to 1) correspond to higher ranking (ranging from 1 to 7) for the anaesthetic success. ALPRA, alprazolam; ACM, acetaminophen; HC, hydrocodone; DEXA, dexamethasone; NSAID, nonsteroidal antiinflammatory drug; TRAMA, Tramadol. association did not reach significance for acetaminophen at any dose, alprazolam and some other combinations ( Fig. 5 and Table S7 ). Pairwise and network meta-analytic results of all interventions for the efficacy outcome at subgroup analysis are presented in Fig. 6 . Network estimates were comparable to those from standard pairwise meta-analysis at subgroup analysis. SUCRA rank and SUCRA curves for all intervention in subgroup analysis are presented in Table S7 and Figure S8 .
Network consistency and small study effects
Assessment of inconsistency for the efficacy outcome in primary network analysis, sensitivity analyses and subgroup analysis are presented in Table S8 . No difference was observed between the consistency and inconsistency models after applying the test of global inconsistency that allowed assessment of network coherence. No evidence of small study effects could be identified on the basis of funnel plot asymmetry using comparisonadjusted funnel plots ( Figures S9, S10 (a-d) ).
GRADE summary of evidence
GRADE summary of evidence from network metaanalyses for interventions, demonstrating the evidence of efficacy, is presented in Table S9 . Overall, there was no serious ROB, inconsistency, indirectness or publication bias for any of the direct comparisons. On applying GRADE criteria to findings from the network meta-analysis combining direct and indirect evidence, high, moderate and low confidence in estimates was shown supporting the use of NSAIDs, dexamethasone and Tramadol, respectively, when each of the premedications was compared to placebo for the success of IANB anaesthesia. High quality was assigned to the estimate that demonstrated no difference for the comparison of NSAIDs with the combination of NSAIDs and acetaminophen.
Discussion
Achieving successful anaesthesia in mandibular molars diagnosed with irreversible pulpitis is more difficult compared to teeth with normal pulps (Modaresi et al. 2006) . Previous meta-analyses (Li et al. 2012 , Lapidus et al. 2016 , Corbella et al. 2017 , Shirvani et al. 2017 , Tupyota et al. 2017 reported that oral premedication with NSAIDs increased the success rate of IANB in teeth with irreversible pulpitis. However, the effect of various premedication drugs could not be compared to each other as they were not studied in head-to-head trials. Furthermore, the existing scientific literature did not provide an answer for the dental practitioner as to the ranking amongst the various Oral premedication and anaesthetic efficacy Pulikkotil et al.
oral premedications that are effective in increasing IANB success. The present systematic review and network meta-analysis is the first study to identify the most efficient oral premedication to increase the success rate of IANB in patients with irreversible pulpitis by combining direct and indirect evidence from 19 RCTs comprising 1654 participants.
From the results of pairwise meta-analysis, dexamethasone, NSAID and a combination of NSAID and acetaminophen were associated with an increased IANB success compared to placebo. From the results of the network meta-analysis, dexamethasone, a glucocorticoid with anti-inflammatory effect, ranked first in increasing the success rate of IANB compared to other drugs. The results of this study confirmed the work of Shahi et al. (2013) , who demonstrated that dexamethasone increased the efficacy of IANB compared to ibuprofen. Dexamethasone is a glucocorticoid and affects the acute inflammatory response by suppressing vasodilation, preventing the migration and phagocytosis of polymorphonuclear leucocytes, inhibiting the production of prostaglandins (PGs) and leukotrienes through blocking of COX and lipoxygenase pathways of inflammation (Glassman et al. 1989 , Shahi et al. 2013 . In contrast to its efficacy as an oral premedication, the supplemental use of dexamethasone as a local infiltration did not increase the success rate of IANB (Aggarwal et al. 2011) . NSAIDs ranked second in overall efficacy in increasing the success rate of IANB. NSAIDs were superior to placebo and all other oral premedications except for dexamethasone for increasing the success of IANB anaesthesia, with high confidence in estimates (as per GRADE). The results of this study were comparable to other randomized controlled Figure 6 Pairwise (upper right portion) and network (lower left portion) meta-analytic results for the efficacy of oral premedications on the anaesthetic efficacy of Inferior Alveolar Nerve Block at subgroup analysis. Outcomes are expressed as risk ratios (95% confidence intervals). For the pairwise meta-analyses, risk ratio more than 1 indicates that the treatment specified in the column is more efficacious. For the network meta-analysis, risk ratio more than 1 indicates that the treatment specified in the row is more efficacious. trials (Parirokh et al. 2010 , Noguera-Gonzalez et al. 2013 ) and meta-analyses (Li et al. 2012 , Lapidus et al. 2016 , Corbella et al. 2017 , Shirvani et al. 2017 , Tupyota et al. 2017 . NSAIDs affect the production of prostaglandins (PGs) and thromboxane A2 responsible for mediating inflammation by reversibly inhibiting cyclooxygenase pathway. The decrease in the level of inflammatory mediators leads to reduced nociceptor activation (Aggarwal et al. 2010 , Prasanna et al. 2011 , providing the rationale on the use of NSAIDS as premedication in reducing pain and inflammation in patients with irreversible pulpitis for an increase in the success rate of IANB. Direct (pairwise) and indirect comparison by network meta-analysis did not reveal a significant difference between dexamethasone and NSAIDs. Tramadol was third in rank and was based on a single study. The success of dexamethasone and Tramadol in improving the anaesthetic effect of IANB could also be due to the study population in the Shahi et al. (2013) and Mahajan et al. (2017) studies, wherein the effect of both the drugs (dexamethasone and Tramadol) was assessed in teeth with asymptomatic irreversible pulpitis compared to other randomized controlled trials included in the network meta-analysis. The presence of preoperative pain (symptomatic irreversible pulpitis) can affect the success rate of IANB (Aggarwal et al. 2015) . The success rate of IANB for symptomatic and asymptomatic irreversible pulpitis was 64.2% and 86.9%, respectively (Argueta-Figueroa et al. 2012) . Sensitivity analysis was performed with studies of low risk of bias, using 1.8 mL of anaesthetic solution, using lidocaine anaesthetic solution and by excluding small size trials. The sensitivity analysis showed results similar to the primary network meta-analysis.
Subgroup analysis was performed by evaluating the individual drug and its dosage (25 interventions, including placebo) on the success rate of IANB. In the subgroup analysis, dexamethasone, ketorolac (10 mg) and piroxicam (20 mg) ranked first, second and third. Only ibuprofen dosed at 400 mg and above increased the success rate of IANB, which could be explained as the drug dose-response effect. The results also showed that premedication with acetaminophen (325/1000 mg) did not affect the success rate of IANB compared to placebo. Acetaminophen (325/500 mg) combined with ibuprofen (400 mg) and aceclofenac (100 mg) had a better success rate for the IANB compared to a placebo.
In total, five studies (Singh et al. 2010 , Paul et al. 2011 , Wali et al. 2012 , Jena & Shashirekha 2013 , Jalil et al. 2014 ) presented a high risk of bias, and two studies (Madani et al. 2013 , Mahajan et al. 2017 had some concerns. The common reasons for a 'high risk' and 'some concerns' scores were biased in randomization process followed by measurement of the outcome. Randomization and allocation concealment are important processes in a study that reduces selection and measurement bias. All trials with high risk of bias in this systematic review were found deficient in these two processes. Blinding and concealment of the participants and the study examiners from information on the intervention would have led to better quality studies by reducing bias in selection and measurement.
The GRADE analysis downgraded the quality of evidence on the superiority of dexamethasone over placebo while it was high for the positive effect of NSAID over placebo. The result on the effect of NSAIDs in increasing the success of IANB anaesthesia can be considered as reliable and valid evidence compared to dexamethasone even though dexamethasone had a higher magnitude on the effect primarily due to the availability of only one randomized controlled trail on dexamethasone. This highlights the need for more high-quality RCTs on dexamethasone to answer this research question. Including acetaminophen with NSAID leads to good effects on IANB anaesthesia and the evidence was of high quality. However, when NSAID + ACM and NSAID were compared, they had equivalent effects and the evidence was of high quality. Until further evidence can be obtained, the addition of acetaminophen to NSAID has little benefit in improving the success rate of NSAID anaesthesia.
This review only included randomized controlled trials, of which 65% were found to be of good quality with low risk of bias. Heterogeneity among studies was minimized by adopting rigorous selection criteria during the design of the systematic review protocol and the standardized independent data abstraction. Various sensitivity analyses (including only low risk of bias, 1.8 mL of anaesthetic solution, lidocaine anaesthetic solution and the exclusion of small size trials) were performed and confirmed the robustness of our primary results. The 'design-by-treatment' interaction model demonstrated that no global measure of inconsistency in networks was observed. Fewer number of randomized controlled trials in assessing the effect premedication on the success rate of IANB anaesthesia limited the support for dexamethasone and Tramadol from the review. The heterogeneity in the presence of preoperative pain among the included studies could affect the results. The present network meta-analysis provided evidence for a number of oral premedication agents to increase the effectiveness of IANB anaesthesia for the treatment of teeth with irreversible pulpitis. The question can be raised whether this warrants a recommendation for clinicians to prescribe these drugs and wait for the onset of analgesia for the treatment of irreversible pulpitis or if they should instead rather resort to supplemental anaesthesia such as periodontal ligament (Nusstein et al. 2005) , or intraosseous anaesthesia , which has been demonstrated to be clinically effective. Oral premedication should be seen as an addition or an alternative supplement in situations where IANB plus supplemental anaesthesia has either reached anaesthetic dose limitations or its effectiveness is decreased. Examples include the inability to completely suppress the graded nerve potential in situations where a patient is suffering from pain due to severe inflammation induced by a large increase of neuropeptides, nerve sprouting, and peripheral sensitization, or reduced effectiveness in case of an increase in the numbers of tetrodotoxinresistant sodium channels. While no general recommendations can be given due to individual pathosis and disease progression, as well as pain thresholds, the practitioner should be aware of the availability and possibility to use these drugs and be prepared to apply them in the situations where it is warranted.
Conclusion
The available evidence from this network meta-analysis demonstrated that oral premedication with dexamethasone, NSAIDs and Tramadol increases the success rate of IANB in teeth with irreversible pulpitis. Future high-quality randomized controlled trials are required to confirm the results of this network meta-analysis on the use of dexamethasone or Tramadol in treating patients with symptomatic irreversible pulpitis.
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